EUVIMEDEUVIMED entdecken
Open Access

Safety evaluation of the food enzyme AMP deaminase from the genetically modified Bacillus subtilis strain CCTCC M 2023264

EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L M Solano, Henk Van Loveren und 3 weitere

EFSA Journal · 01.04.2026 · 24 (4) · e10029-e10029

DOI: 10.2903/j.efsa.2026.10029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EFSA Journal, erschienen am 01.04.2026. Verfasst von EFSA Panel on Food Enzymes (FEZ) und 14 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

strain CCTCC M 2023264 by Angel Yeast Co., Ltd. The production strain of the food enzyme contains multiple copies of three acquired antimicrobial resistance genes, therefore it does not fulfil the requirements of the qualified presumption of safety approach to safety assessment. However, considering the absence of viable cells and DNA from the production organism in the food enzyme, this is not considered to be a risk. As no other concerns arising from the microbial source and its subsequent genetic modification or from the manufacturing process have been identified, the Panel considered that toxicological tests are not needed for the assessment of this food enzyme. The food enzyme is intended to be used in the processing of yeast and yeast products. Dietary exposure was estimated to be up to 0.006 mg total organic solids/kg body weight per day in European populations. A search for the homology of the amino acid sequence of the AMP deaminase to known allergens was made and no match was found. The Panel considered that a risk of allergic reactions upon dietary exposure cannot be excluded, but that the likelihood is low. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use.

Schlagwörter

Stichwörter der Autor:innen

AMP aminohydrolaseAMP deaminaseBacillus subtilisEC 3.5.4.6EFSA‐Q‐2024‐00731food enzymegenetically modified microorganism

Zitieren

APA

EFSA Panel on Food Enzymes (FEZ), Zorn, H., Barat Baviera, J. M., Bolognesi, C., Catania, F., Gadermaier, G., Greiner, R., Mayo, B., Mortensen, A., Roos, Y. H., Solano, M. L. M., Van Loveren, H., Vernis, L., Andryszkiewicz, M., & Liu, Y. (2026). Safety evaluation of the food enzyme AMP deaminase from the genetically modified Bacillus subtilis strain CCTCC M 2023264. EFSA Journal, 24(4), e10029-e10029. https://doi.org/10.2903/j.efsa.2026.10029

Vancouver

EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, et al. Safety evaluation of the food enzyme AMP deaminase from the genetically modified Bacillus subtilis strain CCTCC M 2023264. EFSA Journal. 2026;24(4):e10029-e10029. doi:10.2903/j.efsa.2026.10029

BibTeX
@article{EFSAPanelonFoodEnzymesFEZ2026,
  author = {EFSA Panel on Food Enzymes (FEZ), EFSA Panel on Food Enzymes (FEZ) and Zorn, Holger and Barat Baviera, José Manuel and Bolognesi, Claudia and Catania, Francesco and Gadermaier, Gabriele and Greiner, Ralf and Mayo, Baltasar and Mortensen, Alicja and Roos, Yrjö Henrik and Solano, Marize L M and Van Loveren, Henk and Vernis, Laurence and Andryszkiewicz, Magdalena and Liu, Yi},
  title = {Safety evaluation of the food enzyme AMP deaminase from the genetically modified Bacillus subtilis strain CCTCC M 2023264},
  journal = {EFSA Journal},
  year = {2026},
  volume = {24},
  number = {4},
  pages = {e10029--e10029},
  doi = {10.2903/j.efsa.2026.10029}
}
Kostenlos starten →